AndhraNews.net
Home » Features » Education » Stanford University School of Medicine

Stanford University School of Medicine


About Stanford University School of Medicine

Stanford University School of Medicine in News

Milken Institute Center for the Future of Aging Assembles Top Experts on Aging
LOS ANGELES, CA--(Marketwired - December 01, 2015) - The Milken Institute today announced the creation of an advisory board to help shape the agenda of its new Center for the Future of Aging.

A Subset of Patients With Metastatic Melanoma Achieves Clinical Benefit From Combination of Immunotherapy and Radiation Therapy
SAN ANTONIO, TX--(Marketwired - October 19, 2015) - Immunotherapy combined with palliative radiation therapy (RT) for a subset of patients with metastatic melanoma reduces the growth and spread of the cancer, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 57th Annual Meeting.

Third Annual International Conference on Human Milk Science & Innovation Concludes With New Research on Medical Applications in the NICU and Beyond
PASADENA, CA--(Marketwired - September 16, 2015) - The third annual International Conference on Human Milk Science and Innovation was held last week in Pasadena, Calif., with international researchers presenting the latest scientific discoveries and clinical data related to the use of human milk.

Pieris Pharmaceuticals Appoints Immuno-Oncology Expert, Holbrook Kohrt, M.D., Ph.D., to Spearhead Immuno-Oncology Efforts and Initiates Research Collaboration With Leading Cancer Research Center
FREISING, GERMANY--(Marketwired - May 14, 2015) - Pieris Pharmaceuticals, Inc. (OTCQB: PIRS), a biotechnology company advancing its patented and proprietary Anticalin® biotherapeutic technologies, announced today that it has engaged Dr. Holbrook Kohrt, M.D., Ph.D. as Senior Advisor Translational Medicine Immuno-oncology.

NuGene International, Inc. Adds Dr. Mitchell Goldman to Advisory Board
NuGene International, Inc. ("NuGene") (OTCQB: NUGN), the maker of age-defying aesthetic products for skin and hair rejuvenation, has added Dr. Mitchell Goldman, noted dermatologist and co-founder of SkinMedica®, to its advisory board effective April 1, 2015.

diaDexus, Inc. Announces Appointment of John Curnutte, M.D., Ph.D. to Its Board of Directors
diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced the appointment of John Curnutte, M.D., Ph.D. as an independent member of its board of directors effective immediately. Dr. Curnutte will serve on the compensation committee. The Company also announced that Adeoye (Oye) Olukotun, M.D

Zenmark Verbal Design Names ClickWell for Stanford Health Care
Zenmark, a full service verbal design agency, developed the name ClickWell for Stanford Health Care's new online medical service.

Access to High-Quality Cancer Care Eliminates Racial Disparities in Survival, Study Finds
FORT WASHINGTON, PA--(Marketwired - January 27, 2015) - African-American people diagnosed with colon cancer have consistently lower survival rates compared with white patients, despite a nationwide decline in colon cancer deaths overall [1]

Cocrystal Pharma, Inc. Announces Stock Symbol Change from BZNE to COCP
BOTHELL, WA--(Marketwired - April 16, 2014) - Cocrystal Pharma, Inc. (the "Company") (OTCQB: COCP) (OTCBB: BZNE), announced today that, effective April 15, 2014, the Company's stock began trading under the new symbol "COCP". The updated stock trading symbol marks the successful completion of the Company's recent merger with Biozone Pharmaceuticals, Inc., as announced on January 3, 2014.

Cocrystal Pharma and RFS Pharma Merge to Create Advanced Antiviral Development Organization
BOTHELL, WA and ATLANTA, GA--(Marketwired - November 25, 2014) - Cocrystal Pharma, Inc. (OTCQB: COCP), a biotechnology company developing novel antiviral therapeutics for human diseases, today announced the closing of its merger with RFS Pharma, LLC, a privately owned biotech company founded by renowned drug developer, Dr. Raymond Schinazi

Horizon Pharma plc Announces Presentation of Data Showing Unmet Need in Rheumatoid Arthritis and the Positive Effect of RAYOS(R) (Prednisone) Delayed-Release Tablets in Reducing Joint Stiffness of RA Throughout the Day

Napa Valley Plastic Surgeon Authors Blog Series Revealing All About Abdominoplasty
At the Aesthetic Surgery Center of Napa Valley, Dr. John P. Zimmermann prioritizes patient education to enable his patients to make informed decisions about their surgery. As part of this endeavor, he recently authored a series of blog posts dedicated to the tummy tuck procedure.

Napa Valley Plastic Surgeon Discusses the Differences Between Breast Implant Types
At the Aesthetic Surgery Center of Napa Valley, board-certified plastic surgeon John Zimmermann, MD enters breast augmentation consultations with the goal of determining the best course of action for each individual patient. Because no two women's bodies are exactly the same, Dr

AntriaBio Announces Formation of Scientific Advisory Board
AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics to treat patients with diabetes and metabolic disease, announced today the formation of its Scientific Advisory Board (SAB) with five key appointments: Fredric B. Kraemer, M.D., Philip Home, M.A., D.Phil., D.M., F.R.C.P., Jerrold Olefsky, M.D., Andrew R. Hoffman, M.D., and Hoyoung Huh, M.D., Ph.D

4th Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference Taking Place March 27, 2014 in New York City
The 4th Annual "Cancer Immunotherapy: A Long-Awaited Reality" conference will take place on March 27, 2014 at the New York Academy of Medicine in New York City

Knoxville Bariatric Surgeon and Bari Life Bariatric Supplements Introduces Multi-Probiotics
Dr. Stephen G. Boyce, a board-certified Knoxville bariatric surgeon and developer of Bari Life Bariatric Supplements, says he is excited to add multi-probiotics to his line of bariatric vitamin products. According to a recent Stanford University School of Medicine study, supplementing weight loss surgery patients with probiotics can be beneficial for maximizing weight loss benefits. Dr

UPDATE: Biozone Completes Acquisition of Cocrystal Discovery and Begins Transformation to High Growth Biotech Company
ENGLEWOOD CLIFFS, NJ--(Marketwired - January 03, 2014) - Biozone Pharmaceuticals, Inc. (OTCQB: BZNE) today announced that it has finalized its planned merger with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases

Biozone Completes Acquisition of Cocrystal Discovery and Begins Transformation to High Growth Biotech Company
ENGLEWOOD CLIFFS, NJ--(Marketwired - January 03, 2014) - Biozone Pharmaceuticals, Inc. (OTCQB: BZNE) today announced that it has finalized its planned merger with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases

Biocon Academy’s Flagship Program in Collaboration with KGI Takes Off to a Flying Start
Biocon Academy, a one-of-its-kind Centre of Excellence for Advanced Learning in Applied Bio-Sciences, today announced the commencement of its flagship program – the ‘Biocon KGI Certificate Program in Biosciences’ – in collaboration with Keck Graduate Institute in Claremont, California

Orgenesis CSO & Founder, Dr. Sarah Ferber, to Present at the 2013 World Stem Cell Summit on December 4
Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver cells into functioning insulin-producing cells, has been invited to present at the 2013 World Stem Cell Summit on Wednesday, December 4, 2013 at the Manchester Grand Hyatt in San Diego.

Biozone Pharmaceuticals Announces Executed Letter of Intent to Merge With Cocrystal Discovery Inc.
ENGLEWOOD CLIFFS, NJ--(Marketwired - November 27, 2013) - Biozone Pharmaceuticals, Inc. (OTCBB: BZNE) today announced that it has agreed to terms and signed a Letter of Intent to merge with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases

Actelion launches VALCHLOR (mechlorethamine) gel 0.016% in the US
Actelion Pharmaceuticals Ltd /Actelion launches VALCHLOR (mechlorethamine) gel 0.016% in the US. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

PointCare Donates Screening Software to Stanford Medical Students' Pacific Free Clinic to Speed ACA Enrollment
PointCare, a patient advocacy-focused software company, has donated the use of its web-based, point-of-service screening program to the Stanford University School of Medicine's Pacific Free Clinic to support the important and much-needed service it provides to the community.

The Aesthetic Surgery Center of Napa Valley Launches a New Website to Improve Patient Care
Dr. John Zimmermann, a plastic surgeon in Napa Valley, recently announced the launch of a newly redesigned website for his practice. The new layout and design makes it easier for his patients to navigate through topics and information available on the site, he says. Dr

Prima BioMed Updates Clinical Leadership Team
Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", the "Company") is pleased to announce that Holbrook Kohrt, MD, PhD and Pamela Klein, MD have been brought on as senior clinical advisors for the CVac development programs. The two professionals will work with Dr

Singapore Scientist Wins Coveted Chen New Investigator Award 2013
Dr Patrick Tan from A*STAR's Genome Institute of Singapore (GIS) has received the 2013 Chen New Investigator Award from the international Human Genome Organisation (HUGO)

Athersys: Short Term Catalyst With Long Term Potential
In 2012, many stem cell stocks experienced fast-paced growth as new and promising research continues to propel the industry forward.

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy
The Government of India’s Department of Biotechnology (DBT) and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India. Data from the trial, presented today at the International Symposium on Rotavirus Vaccines for India—The Evidence and the Promise, showed ROTAVAC® to have an excellent safety and efficacy profile

Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease
Cook Medical has received U.S. Food and Drug Administration (FDA) marketing approval for the first devices in its Zilver® PTX® Drug-Eluting Peripheral Stent portfolio, company officials reported today. It’s the first time the FDA has approved a drug-eluting stent to treat blockages in a peripheral artery.

Dr. William Boothe: PRK Dry Eye Risk Not Lower Than That Associated With LASIK Procedures
The medical community often has several different procedures that can be used to treat one condition. These varying options are generally recommended depending upon their side effects and the medical history of the patient. One example of this is the recommendation of photorefractive keratectomy, or PRK, over LASIK

New Studies Confirm Value of Given Imaging's PillCam(R) SB in Managing Pediatric Patients With Inflammatory Bowel Disease
Given Imaging (NASDAQ: GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that new studies confirm the value of its PillCam® SB as a tool to help monitor, diagnose and manage pediatric patients with inflammatory bowel diseases (IBD) including Crohn's disease

Hamilton Thorne Receives FDA Clearance on Its Multi-Pulse Software for Clinical Applications
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that the Company's Multi-Pulse software has received FDA clearance for performing embryo biopsy in clinical settings

iRhythm Announces National Registry Data Demonstrating That Zio(R) Patch Increases Diagnostic Yield in Arrhythmia Detection
iRhythm Technologies, Inc., a medical device and service company that develops and markets simple, innovative diagnostic monitoring solutions, today announced that positive clinical results regarding its Zio® Patch cardiac rhythm monitoring system were presented at the American College of Cardiology's 61st Annual Scientific Session (ACC.12) in Chicago.

iRhythm Announces Upcoming Presentations of Zio(R) Patch Data at Heart Rhythm Society's Annual Scientific Session
iRhythm Technologies, Inc., a medical device and service company that develops and markets simple, innovative diagnostic monitoring solutions, today announced that two studies of its Zio® Patch cardiac rhythm monitoring system will be presented at the Heart Rhythm Society (HRS) 33rd Annual Scientific Sessions in Boston

Research Team Discovers Four-Fold Improvement in Ability to Restore Lymphatic Function With Adenovirally-Delivered VEGF-C Gene Therapy After Lymph Node Transplant Surgery Compared to the Surgery Alone
Lymphedema Awareness Day was established to support the needs of patients with lymphedema and to raise awareness for the need to develop new treatment options

Scientists slam proposed testosterone testing of some female Olympians
A Stanford University School of Medicine bioethicist and her colleagues have criticised proposed Olympic policies for testing the testosterone levels of select female athletes, saying that it could discriminate against women who may not meet traditional notions of femininity and distort the scientific evidence on the relationship between testosterone, sex and athletic performance.

Antioxidant lowers irritability and repetitive behaviors in autistic kids
A specific antioxidant supplement may be an effective therapy for some features of autism.

New prosthetic retina may help restore sight to blind people
Scientists at the Stanford University School of Medicine have devised a system using tiny solar-panel-like cells surgically placed underneath the retina, which may someday restore sight to people who have lost vision because of certain types of degenerative eye diseases.

New type of retinal prosthesis may help restore sight to blind people
Scientists at the Stanford University School of Medicine have devised a system using tiny solar-panel-like cells surgically placed underneath the retina, which may someday restore sight to people who have lost vision because of certain types of degenerative eye diseases.

Protein used to treat cancer modified to boost potency, reduce toxicity
Scientists have improved potency and reduced side effects of a naturally occurring protein used to treat cancers.

Alcoholism's short-term effects on memory functioning could be harmful
Alcoholism can disrupt memory functioning prior to later-stage Korsakoff's syndrome - a neurological disorder usually related to alcohol abuse, according to a new study.

1 in 100 people 'insensitive to HIV, malaria, leprosy and hepatitis'
One per cent of the population have a natural genetic resistance to deadly disease such as HIV, malaria, leprosy and hepatitis, scientists have revealed, scientists have revealed.

Women feel pain more intensely than men
After analysis of a huge collection of electronic medical records, scientists including one of an Indian-origin have found that women report more intense pain than men in virtually every disease category.

New therapies to replace damaged tissues come closer to reality
Researchers have now identified an important gene that plays a role in normal development of lungs and brain, which may lead to lead to new ways to replace damaged tissues in the lung and other organs with stem cells

Scar findings may pave way for new treatments of fibrotic diseases
Scientists have identified the molecular pathway through which physical force contributes to scarring.

1st recurrent gene fusion in ovarian cancer identified
Researchers at the Stanford University School of Medicine have for the first time identified a recurrent gene fusion in ovarian cancer - a discovery that could lead to earlier diagnoses and future therapies.

Child's IQ doesn't determine dyslexia
Schools and psychologists have historically relied on a child's IQ to define and diagnose dyslexia, a brain-based learning disability that impairs a person's ability to read.

Men without kids 'likelier to die from heart problems'
Childless men are more likely to die from cardiovascular disease than for fathers, says a large study by the Stanford University School of Medicine.

Soon, computers to tell your intensity of pain
The need for a better way to objectively measure the presence or absence of pain instead of relying on patient self-reporting has long been an elusive goal in medicine.

Blood protein that cause ageing in brains of mice identified
Researchers from Stanford University School of Medicine have discovered that giving old mice blood from their younger counterparts result in a three-fold increase in the number of brain cells critical to memory and learning.

New way to 'tame' malaria parasite identified
Researchers at the Stanford University School of Medicine and the University of California-San Francisco have developed a novel technique to "tame" the malaria parasite, by forcing it to depend on an external supply of a vital chemical.

Sutureless method for joining blood vessels developed
Severe blood vessels have always been reconnected with the help of sutures, but now a team of researchers at the Stanford University School of Medicine has developed a sutureless method that appears to be a faster, safer and easier alternative.

Possible trigger behind epileptic seizures identified
A brain-circuit defect that triggers absence seizures- the most common form of childhood epilepsy- have been identified by the researchers at the Stanford University School of Medicine.

Stanford researchers identify new molecular target for diabetes therapy
Artificially activating a key molecular pathway responsible for the natural decrease in the proliferation of insulin-producing cells that occurs as a person ages could one day lead to a new way to combat diabetes, say researchers at the Stanford University School of Medicine.

Comment on this story

Share